XML 20 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Net sales $ 1,668.3 $ 1,391.5 $ 1,216.1
Cost of sales 1,098.2 878.7 750.6
Gross profit 570.1 512.8 465.5
Selling, general, and administrative expenses 198.8 179.3 149.4
Research and technical expenses 30.3 26.3 22.6
Restructuring and other (income) charges, net 13.8 16.2 18.5
Acquisition-related costs 5.0 0.6 1.8
Other (income) expense, net (1.7) 79.9 (4.1)
Interest expense 61.8 51.7 47.1
Interest income (7.5) (4.0) (4.9)
Income (loss) before income taxes 269.6 162.8 235.1
Provision (benefit) for income taxes 58.0 44.7 53.7
Net income (loss) $ 211.6 $ 118.1 $ 181.4
Per share data      
Basic earnings (loss) per common share attributable to Ingevity stockholders (usd per share) $ 5.54 $ 2.97 $ 4.39
Diluted earnings (loss) per common share attributable to Ingevity stockholders (usd per share) $ 5.50 $ 2.95 $ 4.37